731
Views
0
CrossRef citations to date
0
Altmetric
Hematology

Molecular understanding of unusual HbE-β+-thalassemia with Hb phenotype similar to HbE heterozygote: simple and rapid differentiation using HbE levels

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2267054 | Received 24 Jul 2023, Accepted 30 Sep 2023, Published online: 10 Oct 2023

References

  • Weatherall DJ, Clegg JB. The thalassemia syndromes., 4th ed. Blackwell Science, Oxford, 2001;Database]
  • Yamsri S, Singha K, Prajantasen T, et al. A large cohort of β(+)-thalassemia in Thailand: molecular, hematological and diagnostic considerations. Blood Cells Mol Dis. 2015;54(2):1–14. doi: 10.1016/j.bcmd.2014.11.008.
  • Vichinsky E. Hemoglobin E syndromes. Hematology Am Soc Hematol Educ Program. 2007;2007(1):79–83. doi: 10.1182/asheducation-2007.1.79.
  • Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin. 1987;11(1):65–88. doi: 10.3109/03630268709036587.
  • Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res. 2011;134(4):498–506.
  • Winichagoon P, Thonglairoam V, Fucharoen S, et al. Severity differences in beta-thalassaemia/haemoglobin E syndromes: implication of genetic factors. Br J Haematol. 1993;83(4):633–639. doi: 10.1111/j.1365-2141.1993.tb04702.x.
  • Sae-Ung N, Srivorakun H, Fucharoen G, et al. Phenotypic expression of hemoglobins A2, E and F in various hemoglobin E related disorders. Blood Cells Mol Dis. 2012;48(1):11–16. doi: 10.1016/j.bcmd.2011.09.008.
  • Yamsri S, Pakdee N, Fucharoen G, et al. Molecular understanding of non-transfusion-dependent thalassemia associated with hemoglobin E-β-thalassemia in Northeast Thailand. Acta Haematol. 2016;136(4):233–239. doi: 10.1159/000449120.
  • Jomoui W, Tepakhan W, Yamsri S, et al. A novel SNP rs11759328 on Rho GTPase-activating protein 18 gene is associated with the expression of Hb F in hemoglobin E-related disorders. Ann Hematol. 2020;99(1):23–29. doi: 10.1007/s00277-019-03862-0.
  • Tepakhan W, Yamsri S, Sanchaisuriya K, et al. Nine known and five novel mutations in the erythroid transcription factor KLF1 gene and phenotypic expression of fetal hemoglobin in hemoglobin E disorder. Blood Cells Mol Dis. 2016;59:85–91. doi: 10.1016/j.bcmd.2016.04.010.
  • Fucharoen S, Winichagoon P. Clinical and hematologic aspects of hemoglobin E beta-thalassemia. Curr Opin Hematol. 2000;7(2):106–112. doi: 10.1097/00062752-200003000-00006.
  • Fucharoen S, Weatherall DJ. The hemoglobin E thalassemias. Cold Spring Harb Perspect Med. 2012;2(8):a011734–a011734. doi: 10.1101/cshperspect.a011734.
  • Sanchaisuriya K, Chirakul S, Srivorakun H, et al. Effective screening for double heterozygosity of Hb E/alpha0-thalassemia. Ann Hematol. 2008;87(11):911–914. doi: 10.1007/s00277-008-0520-x.
  • Ahmad NN, Cu-Unjieng AB, Donoso LA. Modification of standard proteinase K/phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet. 1995;32(2):129–130. doi: 10.1136/jmg.32.2.129.
  • Sirichotiyakul S, Saetung R, Sanguansermsri T. Analysis of beta-thalassemia mutations in Northern Thailand using an automated fluorescence DNA sequencing technique. Hemoglobin. 2003;27(2):89–95. doi: 10.1081/hem-120021541.
  • Sae-Ung N, Fucharoen G, Sanchaisuriya K, et al. Alpha(0)-thalassemia and related disorders in northeast Thailand: a molecular and hematological characterization. Acta Haematol. 2007;117(2):78–82. doi: 10.1159/000096857.
  • Fucharoen S, Fucharoen G, Sanchaisuriya K, et al. Molecular analysis of a Thai beta-thalassaemia heterozygote with normal haemoglobin A2 level: implication for population screening. Ann Clin Biochem. 2002;39(Pt 1):44–49. doi: 10.1258/0004563021901720.
  • Fucharoen S, Sanchaisuriya K, Fucharoen G, et al. Interaction of hemoglobin E and several forms of alpha-thalassemia in cambodian families. Haematologica. 2003;88(10):1092–1098.
  • Ruengdit C, Khamphikham P, Jinorose N, et al. Hb bart’s hydrops fetalis syndrome and Hb H disease caused by deletional Chiang Rai (- -CR) α0-Thalassemia in two unrelated Thai families. Hemoglobin. 2021;45(2):75–79. doi: 10.1080/03630269.2021.1906269.
  • Khalil MS, Timbs A, Henderson S, et al. Haemoglobin (Hb) G-Philadelphia, Hb Stanleyville-II, Hb G-Norfolk, Hb Matsue-Oki and Hb Mizushi can form a panel of α-chain variants that overlap in their phenotype: the novel use of StyI to screen for Hb G-Philadelphia. Int J Lab Hematol. 2011;33(3):318–325. doi: 10.1111/j.1751-553X.2010.01289.x.
  • Fucharoen S, Shimizu K, Fukumaki Y. A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression. Nucleic Acids Res. 1990;18(17):5245–5253. doi: 10.1093/nar/18.17.5245.
  • Kattamis AC, Camaschella C, Sivera P, et al. Human alpha-thalassemia syndromes: detection of molecular defects. American J Hematol. 1996;53(2):81–91. doi: 10.1002/(SICI)1096-8652(199610)53:2≤81::AID-AJH5≥.0.CO;2-#.
  • Singha K, Taweenan W, Fucharoen G, et al. Erythrocyte indices in a large cohort of β-thalassemia carrier: implication for population screening in an area with high prevalence and heterogeneity of thalassemia. Int J Lab Hematol. 2019;41(4):513–518. doi: 10.1111/ijlh.13035.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi: 10.1182/blood-2016-03-643544.
  • Gangat N, Szuber N, Pardanani A, et al. JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views. Leukemia. 2021;35(8):2166–2181. doi: 10.1038/s41375-021-01290-6.
  • Nuntakarn L, Fucharoen S, Fucharoen G, et al. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand. Blood Cells Mol Dis. 2009;42(1):32–35. doi: 10.1016/j.bcmd.2008.09.002.
  • Nuinoon M, Makarasara W, Mushiroda T, et al. A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E. Hum Genet. 2010;127(3):303–314. doi: 10.1007/s00439-009-0770-2.
  • Sanchaisuriya K, Fucharoen G, Sae-Ung N, et al. Molecular and hematologic features of hemoglobin E heterozygotes with different forms of alpha-thalassemia in Thailand. Ann Hematol. 2003;82(10):612–616. doi: 10.1007/s00277-003-0689-y.
  • Satthakarn S, Panyasai S, Pornprasert S. Molecular characterization of β- and α-globin gene mutations in individuals with borderline Hb A2 levels. Hemoglobin. 2020;44(5):349–353. doi: 10.1080/03630269.2020.1826327.
  • Yang KG, Kutlar F, George E, et al. Molecular characterization of beta-globin gene mutations in Malay patients with Hb E-beta-thalassaemia and thalassaemia major. Br J Haematol. 1989;72(1):73–80. doi: 10.1111/j.1365-2141.1989.tb07655.x.
  • Ma SK, Chow EY, Chan AY, et al. Beta-thalassemia intermedia caused by compound heterozygosity for Hb Malay (beta codon 19 AAC–>AGC; asn–>Ser) and codons 41/42 (-CTTT) beta(0)-thalassemia mutation. American J Hematol. 2000;64(3):206–209. doi: 10.1002/1096-8652(200007)64:3≤206::aid-ajh12≥3.0.co;2-#.
  • Bardakdjian-Michau J, Fucharoen S, Delanoe-Garin J, et al. Hemoglobin Dhonburi alpha 2 beta 2 126 (H4) Val–Gly: a new unstable beta variant producing a beta-thalassemia intermedia phenotype in association with beta zero-thalassemia. Am J Hematol. 1990;35(2):96–99. doi: 10.1002/ajh.2830350206.
  • Viprakasit V, Chinchang W. Two independent origins of Hb Dhonburi (Neapolis) [beta 126 (H4) val–>gly]: an electrophoretically silent hemoglobin variant. Clin Chim Acta. 2007;376(1-2):179–183. doi: 10.1016/j.cca.2006.08.016.
  • Tepakhan W, Yamsri S, Fucharoen G, et al. Krüppel-like factor 1 mutations and expression of hemoglobins F and A2 in homozygous hemoglobin E syndrome. Ann Hematol. 2015;94(7):1093–1098. doi: 10.1007/s00277-015-2335-x.
  • Khalil MSM, Timbs AT, Henderson SJ, et al. Fifteen cases of Hb J-Meerut: the rare association with Hb E and/or HBA1: c. 24C>G (or HBA2) variants. Hemoglobin. 2020;44(5):364–367. doi: 10.1080/03630269.2020.1817755.
  • Khalil MSM, Timbs AT, Henderson SJ, et al. Eight cases of Hb Winnipeg [HBA2: c.226G > T (or HBA1)]: a detailed study. Hemoglobin. 2021;45(4):256–258. doi: 10.1080/03630269.2021.1976203.
  • Viprakasit V, Ekwattanakit S, Chalaow N, et al. Clinical presentation and molecular identification of four uncommon alpha globin variants in Thailand. Initiation codon mutation of α2-globin gene (HBA2:c.1delA), donor splice site mutation of α1-globin gene (IVSI-1, HBA1:c.95 + 1G > a), hemoglobin Queens Park/Chao pra Ya (HBA1:c.98T > A) and hemoglobin Westmead (HBA2:c.369C>G). Acta Haematol. 2014;131(2):88–94. doi: 10.1159/000353119.
  • Winichagoon P, Fucharoen S, Chen P, et al. Genetic factors affecting clinical severity in beta-thalassemia syndromes. J Pediatr Hematol Oncol. 2000;22(6):573–580. doi: 10.1097/00043426-200011000-00026.
  • Winichagoon P, Fucharoen S, Weatherall D, et al. Concomitant inheritance of alpha-thalassemia in beta 0- thalassemia/Hb E disease. Am J Hematol. 1985;20(3):217–222. doi: 10.1002/ajh.2830200303.
  • Olivieri NF, Pakbaz Z, Vichinsky E. HbE/β-thalassemia: basis of marked clinical diversity. Hematol Oncol Clin North Am. 2010;24(6):1055–1070. doi: 10.1016/j.hoc.2010.08.008.
  • Mohammad SNNA, Iberahim S, Wan Ab Rahman WS, et al. Single nucleotide polymorphisms in XMN1-HBG2, HBS1L-MYB, and BCL11A and their relation to high fetal hemoglobin levels that alleviate anemia. Diagnostics. 2022;12(6):1374. doi: 10.3390/diagnostics12061374.